Literature DB >> 22868758

Structural plasticity of tubulin assembly probed by vinca-domain ligands.

Fanomezana M Ranaivoson1, Benoît Gigant, Simon Berritt, Madeleine Joullié, Marcel Knossow.   

Abstract

Vinca-domain ligands are compounds that bind to tubulin at its inter-heterodimeric interface and favour heterogeneous protofilament-like assemblies, giving rise to helices and rings. This is the basis for their inhibition of microtubule assembly, for their antimitotic activities and for their use in anticancer chemotherapy. Ustiloxins are vinca-domain ligands with a well established total synthesis. A 2.7 Å resolution structure of ustiloxin D bound to the vinca domain embedded in the complex of two tubulins with the stathmin-like domain of RB3 (T(2)R) has been determined. This finding precisely defines the interactions of ustiloxins with tubulin and, taken together with structures of other vinca-ligand complexes, allows structure-based suggestions to be made for improved activity. These comparisons also provide a rationale for the large-scale polymorphism of the protofilament-like assemblies mediated by vinca-domain ligands based on local differences in their interactions with the two tubulin heterodimers constituting their binding site.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868758     DOI: 10.1107/S0907444912017143

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  23 in total

1.  Structures of potent anticancer compounds bound to tubulin.

Authors:  Dan E McNamara; Silvia Senese; Todd O Yeates; Jorge Z Torres
Journal:  Protein Sci       Date:  2015-05-27       Impact factor: 6.725

2.  Molecular modeling study, synthesis and biological evaluation of combretastatin A-4 analogues as anticancer agents and tubulin inhibitors.

Authors:  Yang Ping Quan; Li Ping Cheng; Tian Chi Wang; Wan Pang; Fan Hong Wu; Jin Wen Huang
Journal:  Medchemcomm       Date:  2017-12-06       Impact factor: 3.597

3.  A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs.

Authors:  Andrea E Prota; Katja Bargsten; J Fernando Diaz; May Marsh; Carmen Cuevas; Marc Liniger; Christian Neuhaus; Jose M Andreu; Karl-Heinz Altmann; Michel O Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

4.  Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosis.

Authors:  Avijeet Chopra; Amy Anderson; Charles Giardina
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

5.  The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity.

Authors:  Michal Wieczorek; Joseph Tcherkezian; Cynthia Bernier; Andrea E Prota; Sami Chaaban; Yannève Rolland; Claude Godbout; Mark A Hancock; Joseph C Arezzo; Ozhan Ocal; Cecilia Rocha; Natacha Olieric; Anita Hall; Hui Ding; Alexandre Bramoullé; Matthew G Annis; George Zogopoulos; Patrick G Harran; Thomas M Wilkie; Rolf A Brekken; Peter M Siegel; Michel O Steinmetz; Gordon C Shore; Gary J Brouhard; Anne Roulston
Journal:  Sci Transl Med       Date:  2016-11-16       Impact factor: 17.956

Review 6.  Epothilones: From discovery to clinical trials.

Authors:  Stefano Forli
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

7.  Mechanism of mitotic arrest induced by dolastatin 15 involves loss of tension across kinetochore pairs.

Authors:  Manu Lopus
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

8.  Novel Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins with Potent in Vitro and in Vivo Anticancer Activities.

Authors:  Derek C Medellin; Qiong Zhou; Robert Scott; R Matthew Hill; Sarah K Frail; Ramesh Dasari; Steven J Ontiveros; Stephen C Pelly; Willem A L van Otterlo; Tania Betancourt; Charles B Shuster; Ernest Hamel; Ruoli Bai; Daniel V LaBarbera; Snezna Rogelj; Liliya V Frolova; Alexander Kornienko
Journal:  J Med Chem       Date:  2015-12-17       Impact factor: 7.446

9.  Design, synthesis and biological evaluation of imidazopyridine-propenone conjugates as potent tubulin inhibitors.

Authors:  Ibrahim Bin Sayeed; V Lakshma Nayak; Mohd Adil Shareef; Neeraj Kumar Chouhan; Ahmed Kamal
Journal:  Medchemcomm       Date:  2017-03-06       Impact factor: 3.597

10.  Synthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidins.

Authors:  Robert Scott; Menuka Karki; Mary R Reisenauer; Roberta Rodrigues; Ramesh Dasari; W Ross Smith; Stephen C Pelly; Willem A L van Otterlo; Charles B Shuster; Snezna Rogelj; Igor V Magedov; Liliya V Frolova; Alexander Kornienko
Journal:  ChemMedChem       Date:  2014-03-18       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.